NDC 72786-111-02
OXBRYTA 300 mg/1
Voxelotor · TABLET, FOR SUSPENSION
OXBRYTA is a tablet, for suspension containing voxelotor at a strength of 300 mg/1. Manufactured by Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc..
Key Facts
- Brand Name
- OXBRYTA
- Generic Name
- Voxelotor
- NDC Code (Package)
72786-111-02- NDC Code (Product)
72786-111- Manufacturer
- Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.
- Strength
- 300 mg/1
- Dosage Form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA216157
- Drug Class
- Hemoglobin S Polymerization Inhibitor [EPC]
- Marketing Start
- 12/17/2021
Recall History
No Recall HistoryView Full Drug Page
OXBRYTA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.